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Abstract
Background: Since many hospitals report high MRSA colonization rates among elderly patients, and because it has
been shown that S. aureus colonization increases with advancing age, there are concerns about the introduction of
MRSA into nursing homes by MRSA positive patients discharged from hospital. So far, admission screening and
subsequent longitudinal screening in residence homes or screening at time of hospital discharge is not established
on a regular base. On the other hand, MRSA is acquired frequently during hospital stay. Therefore, the MRSA status
of residents remains unclear at the time of re-admission to the residence home. This study was conducted to
evaluate the rate of nasal MRSA carriage among residents and nursing staffs of 2 nursing homes for the elderly, the
potential acquisition of MRSA during a hospital stay and the feasibility to perform direct screening tests in nursing
homes for elderly.
Methods: In a study period of 5 months, possibility of active PCR-based screening for MRSA has been tested within
2 residence homes for the elderly, with the obligation to avoid inconvenience to the daily working time and
working schedule. Residents and staff members were included in the study and positive test results were confirmed
with MRSA culture.
Results: Feasibility of active on site screening in a residence home for the elderly using a rapid PCR method has been
confirmed. 154 of 156 residents participated on baseline testing for all current and new admitted residents. In 9
participating residents with former unknown status, nasal carriage with MRSA was confirmed (5.8%). Among 32
documented and eligible movements between the nursing home and the hospital, MRSA could be confirmed after
return to the residence home in 2 cases (6.3%). MRSA could also be detected in 1 of 14 participating nursing staff (7.1%).
Conclusion: Prevalence of MRSA was in a range that has been observed for nursing homes in Germany in previous
studies. Residents can acquire MRSA during a hospital stay so that further spread after re-admission into the nursing
home cannot be excluded. This study shows that easy to perform direct screening tests in outpatient facilities for nursing
of the elderly are promising tools as part of potential new strategies for transmission and infection control in such
facilities. Additional studies are needed to investigate if screening followed by interventional hygiene measures can
reduce MRSA transmission and infection in such facilities.
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Background
Increased life expectancy and demographic changes
have led to an increase in the proportion of older
people who require medical care in hospitals. In
addition, more and more patients are released early
after in-patient hospital care, but then require care in
outpatient facilities for geriatric nursing or residence
homes [1]. Since many hospitals report high MRSA
colonization rates among elderly patients, and because
it has been shown that S. aureus colonization increases
with advancing age, there are concerns about the intro-
duction of MRSA into nursing homes by MRSA posi-
tive patients discharged from hospital. It is likely that
the prevalence of MRSA within nursing homes is in-
creasing as a result of the increased prevalence of
MRSA within hospitals, which may have been com-
pounded by the considerable movement of patients
from long-stay hospitals to community-based nursing
homes [2]. Once introduced, the subsequent spread of
MRSA between patients would create a reservoir of
MRSA within a nursing home [3], providing the poten-
tial for an outbreak and further hospital outbreaks
when affected nursing home residents require hospital
treatment [2]. Nursing homes provide an ideal environ-
ment for the acquisition and spread of MRSA, since resi-
dents have an increased risk of colonization due to known
risk factors [4–9]. Notably risk factors for pre-existing
colonization and new acquisition within nursing facilities
can be different [8]. MRSA colonization is also a marker
of mortality risk amongst nursing home residents [10, 11].
Additionally, it has been observed that Health Care
Workers (HCW) have an increased risk for colonization and
contribute to the transmission of MRSA and subsequent in-
fections in hospitals and residence homes [12–17].
In Germany, patients who are at risk for colonization
with MRSA are screened at the time of hospital admis-
sion including elderly people from geriatric nursing fa-
cilities and residence homes. Screening at time of
discharge from the hospital is not performed on a regu-
lar basis. This is important because patients with a
negative screening result at time of admission can
colonize during the subsequent hospital stay [18–22].
Based on this, future strategies for the prevention of
MRSA transmission and MRSA infection potentially
need to include admission screening and subsequent
longitudinal screening in residence homes and other
outpatient facilities. This study was conducted to evalu-
ate the rate of nasal MRSA carriage among residents
and nursing staff of two nursing homes for elderly, the
potential risk of MRSA-acquisition for the residents
during a hospital stay and the feasibility to perform dir-
ect screening tests in nursing homes for the elderly as
part of potential new strategies for transmission and in-
fection control in such facilities.
Methods
Study sites
The study was conducted in 2 residence homes for elderly
located in the federal state of Baden-Württemberg,
Germany. Both facilities had a mixed but similar structure
of residents including residents with normal health status
and the ability to participate in social life and activities
within the facility and those with chronic diseases like
renal impairment, diabetes, incontinence with the need
for urinary tract catheters and others. During the study
period, both facilities together provided 138 places for
long term care and additional places for short term and
single day care. Including new admissions and deaths, 154
residents lived in the 2 residence homes during the study
period of which 152 participated on the study.
Study period
The first specimen was collected on 18th of February
2013. The last specimen was processed on 27th of July
2013.
MRSA testing assay
All measurements were performed directly in the facil-
ities using the Xpert® MRSA/SA nasal complete test on
the Gene Xpert® device platform (Cepheid GmbH,
Frankfurt a. M., Germany). The test allows rapid point-
of-care testing for MRSA on nasal specimen swabs col-
lected from the residents and nursing staff. The test also
detects S. aureus without genetic markers for methicillin
resistance (MSSA) at the same time. Here, data for
MSSA were not reported and discussed because there
was no relation to the aim of this study. The test has a
sensitivity and specificity of 88.2 and 98.3% compared to
enrichment broth with subsequent differentiation [23]. A
negative testing result predicts the absence of a positive
MRSA culture by 98.0% if the prevalence is 14.0% [23].
All persons gave written consent before participation
after adequate explanation. An ethical vote was not ne-
cessary because only data in the scope of routine hygiene
prevention were recorded.
Collection and processing of specimen
Collection of nasal specimens was performed according
to manufactures recommendation in the package insert
using a dual swab validated for the test and provided
from the manufacturer. The dual swab was introduced
in both nares and turned around carefully one fold with
slight pressure. Swabs with nasal specimen were proc-
essed according to the manufacturer’s description in the
package insert. The test was performed as point-of-care
test in the residence home in line with the definitions
for point-of-care testing in Germany, as provided in the
Guidelines of the German Medical Association on Qual-
ity Assurance in Medical Laboratory Testing (http://
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www.bundesaertzekammer.de). One tip of the dual swab
was placed into the vial and broken off at the stem. The
vial contains 2 ml of an elution reagent and was deliv-
ered from the manufacturer. The vial was closed with
the cap and mixed at high speed for 10 s using a vortex
mixer. After this, the elution reagent was transferred
into the test cartridge using a sterile transfer pipette
followed by starting the test on the device. The second
tip of the dual swab remained in the original transport
container for culture confirmation in an external labora-
tory if the PCR testing result was positive for MRSA
Storage of specimen
Swabs used for specimen collection during the day were
placed into the plastic transport tube and stored at 6 de-
grees Celsius until processing for MRSA testing. Testing
procedure was done either in the afternoon on the same
day or on the next day at morning.
Measuring regime
Baseline evaluation of the MRSA colonization rate was
performed on all residents already living in the 2 facilities
who were willing to participate in the study. After the
baseline evaluation, screening was focused on newly ad-
mitted residents and residents transferred to the hospital
at the time of return from the hospital or 1 day later. No
measurements were performed in residents at time of
transfer from the facility to a hospital. Fourteen of about
20 nursing staff also volunteered to be tested for MRSA.
Education and assignment
In each facility, collection and processing of the speci-
mens for MRSA testing was assigned to 2 dedicated em-
ployees. The employees received a 3 h education in
specimen collection and the assay from an authorized
technician of the manufacturer. In addition, the first
tests on participants of the study were supervised by the
technician. In order to investigate the technical and
organizational feasibility without inconvenience against
the daily working routine and working time, the dedi-
cated employees decided for each day and on their own
how much specimen they can collect on the individual
day and if sample processing for testing can be per-
formed on the same day or must be scheduled for the
day after. These employees had directive function in the
institution allowing them to adapt working time and
schedule to collect the specimen and perform the tests.
During the study period, assigned employees arranged
their long term holidays in such a way that one of them
was always available at the facility.
Inclusion and exclusion criteria
Only residents and staff members who were 18 years or
older and willing to participate in the study were
included. Residents and staff members with injuries of
the nasal mucosa were excluded.
Data collection from hospitals
For moving patients who were positive for MRSA at
time of re-admission after hospital stay, results for ad-
mission screening in the hospital were collected to allow
differentiation if acquisition took place in the hospital or
if the patient newly acquired MRSA in the resident
home or potentially during transfer to the hospital.
Culture confirmation
To avoid mis-classification, the second swab was sent to a
laboratory for culture confirmation if the PCR-based test-
ing result was positive because a positive result can appear
due to former intermittent colonization. Based on the low
MRSA prevalence in Germany, the positive predictive
value is weak (60.0 – 80.0% or less) making culture con-
firmation essential and in addition, testing for successful
de-colonization is not possible using PCR [6]. Negative
PCR testing results were not confirmed via culture due to
a high negative predictive value. This is in line with com-
mon practice in Germany and underlying recommenda-
tions for screening of asymptomatic carriers [6].
Statistical methods
Microsoft Excel 2010, Version 14.0.4760.10000 was used
for calculating the average age, median of age, standard
deviation of the age for the entire population and 95%
interval of confidence for the average age. Association
between the rate of colonization with MRSA and the af-
filiation to one of the facilities was determined using
Fisher’s exact test.
Transmission control measures
The physician responsible for a resident with a positive
MRSA status was informed in order to decide the need
of a de-colonization procedure. Transmission control
measures for MRSA positive patients were conducted
according to the internal standards.
Documentation of times
The time needed for specimen collection and assay test-
ing was measured by the designed employees. This in-
cluded the time needed for the procedure alone and
additional time that could be attributed to the proce-
dures, i.e. walking time within the facility to visit the
participant for specimen collection. Average time needed
per test and per specimen collection procedure was cal-
culated based on the total time at the end of the study.
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Results
Results of baseline evaluation and new admissions
Baseline measurements including new admissions during
the study period were performed on 102 of 102 residents
in facility 1 (100%) and 52 of 54 residents in facility 2
(96.3%). Baseline characteristics of participating residents
are displayed in Table 1. Distribution of women and men
was not significantly different between the 2 facilities at
the time of baseline measurement (p = 0.69). Participating
residents of facility 1 had an average age of 85.8 years
(95% CI; 84.4 – 87.1) which was significantly higher (p =
0.03) compared to the average age of participating resi-
dents from facility 2 (82.5; 95% CI; 79.9 – 85.1).
Taking both facilities together, 9 out of 154 residents
were positive for MRSA, resulting in a colonization rate
of 5.84% (see Table 2). There was no association between
the rate of colonization with MRSA (p = 0.49) and the
affiliation to either of the facilities using Fisher’s exact
test. There was no significant difference between the age
of residents colonized with MRSA and residents not col-
onized with MRSA (p = 0.47).
Results of testing health care workers
One out of 14 nursing staff who participated on the
study was positive for MRSA (7.1%). This employee was
released from work until successful decolonization was
confirmed via three negative culture results.
Results in moving residents
During the study period, 21 residents negative for MRSA
at baseline were transferred into the hospital due to
medical reasons (see Fig. 1). 20 of them were still MRSA
negative in the nares after return from the hospital to
the residence home. One resident was measured positive
for MRSA after return. Average time of hospital stay for
the 21 residents was three days. Six of the 20 residents
negative for MRSA after the first hospital stay had a sec-
ond hospital stay. All of them remained negative for
MRSA after return to the residence home. Length of stay
for the second hospital stay of these 6 residents was 1, 3,
4, 12, 18 and 40 days, respectively. Three of the 6 resi-
dents who were negative for MRSA after the second
hospital stay had a third hospital stay. Two of them
remained negative after return to the resident home and
one tested positive for MRSA.
Four residents with positive MRSA status at baseline
evaluation were also transferred into the hospital due to
medical reasons so that it was possible to inform the hospi-
tals about the history of MRSA colonization or ongoing
decolonization procedure. Three of them could be decolo-
nized successfully and one not. The first transfers to the
hospital of these four residents were not evaluated concern-
ing potential MRSA acquisition during hospital stay due to
ongoing decolonization procedures. Two of these residents
with successful, culture proved decolonization had a second
hospital stay. Both of these were still negative for MRSA
after return from the hospital. Length of stay for these two
residents was 14 and 41 days, respectively.
In summary, 25 residents were transferred 1, 2 or 3
times to a hospital and returned back. Of these 25 resi-
dents, 17 had 1 transfer (n = 17), 5 had 2 transfers (n =
10) and 3 had 3 transfers (n = 9), resulting in a total
amount of 36 transfers. Four transfers and two residents
were not eligible for evaluation, resulting in a total sum
of 32 transfers and 23 residents who were eligible for
data evaluation. In 2 of 32 transfers (6.3%) or 2 of 23
moving residents (8.7%), MRSA could be detected after
return from the hospital, respectively.
Feasibility
In both facilities, sample collection and processing with
the test could be integrated into the daily working routine
without exceeding the working times. Inconvenience
against the working routine was not been reported. Base-
line evaluation covering all current residents counted for
84 testing procedures in facility 1 and was finished within
14 working days and 6 tests per day. In facility 2, baseline
evaluation counted for 44 testing procedures and was fin-
ished within 11 days and 4 tests per day.
After the 128 testing procedures conducted for baseline
evaluation at the beginning of the study period, an add-
itional 58 tests have been conducted in the subsequent
5 month period. 26 of these have been conducted on
newly admitted residents and 32 on residents after return
from the hospital to evaluate colonization status. This
means that on average 1 testing procedure per 2.6 days
has been conducted when Saturdays and Sundays are in-
cluded or 1 testing procedure per 1,9 days if the 2 week-
end days are excluded.
Table 1 Baseline characteristics of participating residents
Facility Screening rate Age [years] Gender distribution




1 100.0% (102 of 102) 85.8 86.0 59 – 102 36 (35.3%) 66 (64.7%)
2 96.3% (52 of 54) 82.5 84.0 57 – 104 20 (38.5%) 32 (61.3%)
Total 98.7% (154 of 156) 84.7 85.0 57 – 104 56 (36.4%) 98 (63.6%)
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Including all time consuming steps of the testing pro-
cedure, the average time needed for 1 test was 4 min
and 18 s. This includes time for manual procedures until
testing was started and walking time to the testing de-
vice. The maximum time needed in one case was 9 min.
Average time needed for specimen collection was 3 min
and 27 s per specimen, including walking time within
the facility and collection procedure. Maximum time
measured for the collection of a specimen in one case
was 11 min.
Assay performance
One hundred eighty six testing procedures were per-
formed of which two measurements (1.1%) needed to be
repeated due to invalid testing results. All testing results
positive for MRSA could be confirmed via culture as liv-
ing MRSA organisms.
Side effects
No side effects in terms of allergic reactions or injuries
of the mucosa caused by the specimen collection pro-
cedure were observed and reported from either the staff
or the residents.
Discussion
The development and spread of drug resistant bacteria
such as MRSA is a threat for the aging populations that
have appeared in the past 20 years. Infections caused by
MSSA occur more frequently than infections caused by
MRSA, but the latter is associated with significantly higher
mortality (Odds Ratio: 1.9, 95% CI; 1.5 – 2.4; p < 0,001),
morbidity and costs [24].
During the 5-month period of our study, baseline evalu-
ation including subsequent new admissions resulted in an
MRSA-Prevalence of 5.8% (N = 9). This is in line with
prevalence data found in other studies from German resi-
dent homes for the elderly in which MRSA rates between
1.1 – 26.0% (average of 7.5%) has been reported, suggesting
strong facility specific variations as a result of differences in
the distribution of risk factors for MRSA colonization and
infection [25–33]. None of the nine detected MRSA-
positive residents had been identified or known as residents
with a history of MRSA at the time of testing indicating
that routine screening of residents can detect unknown car-
riers in such facilities. This supports further discussions
about the need for intensified screening of residents to
Table 2 Colonization rate of participating residents at baseline










1 97 (95.1%) 83.0 (±7.9) 5 (4.9%) 85.6
2 48 (92.3%) 84.0 (±8.6) 4 (7.7%) 87.0
Total 145 (94.2%) 83.4 (±8.2) 9 (5.8%) 86.2
SD Standard deviation; N number
Fig. 1 Flow chart of transfers to a hospital and returns to the residence home including results about the MRSA status
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reduce the MRSA rate via transmission control measures.
As length of stay in resident homes is normally encompass-
ing the residual life time, MRSA transmission within resi-
dent homes is not rare [7, 8]. In a recently published study,
new acquired MRSA colonization within a nursing facility
was 68.0% related to all colonized residents [8].
In 2 of the 32 eligible transfers (6.3%) involving 23 resi-
dents, MRSA could be detected after the return from the
hospital. In these cases, acquisition of MRSA during the
hospital stay was probably due to a negative screening re-
sult at time of hospital admission. In Germany, people from
residence homes are defined as patients at risk for MRSA
colonization and screened at time of admission to the hos-
pital [6], but screening at time of discharge is not estab-
lished. On the other hand, colonization with MRSA can
occur during hospital stay as reported in relevant studies
involving different patient groups and wards [18–22, 34].
Because screening at time of discharge from the hospital is
not performed on a regular basis in Germany, MRSA status
of these patients remains unknown at time of re-admission
into a residence home or another out-patient facility. In
addition, data from a recently published nationwide cross-
sectional study in residential geriatric nursing facilities in
Germany showed that, with local differences, only 41.0 –
71.0% of the participating facilities are provided with infor-
mation about the presence of multidrug resistant organisms
when a resident is transferred (or returned) from hospital
to residential geriatric nursing [35]. In combination with
the results of our study, this supports further discussions
about the need of admission screening in such facilities, or
the need for screening of MRSA at time of hospital
discharge to avoid MRSA infection in subsequent out-
patient facilities.
Of the 14 participating nursing staff, 1 (7.1%) has been
found to be positive. A colonization rate of 11.0% for
nursing staff in residence homes with similar amount of
residents was reported in a study from Schwaber et al.,
2013 [9]. In this context, substantial MRSA transmission
from residents to HCW’s gown and gloves has already
been reported in residence homes, whereby high contact
activities of daily living confer the highest risk [12]. Hos-
pital based studies found colonization rates of HCW be-
tween 5.0 and 17.0%, a higher risk for colonization of
HCW with frequent and intensive contact to patients
[16, 27] and the contribution of HCW to the transmis-
sion of MRSA and subsequent infections [13, 15]. This
leads to the question if MRSA transmission from colo-
nized residents to nursing staff and from nursing staff to
other residents could be a relevant route of transmission
in residence homes. This question cannot be answered
with the data from this study and needs to be evaluated
in additional investigations.
In terms of organizational and technical feasibility,
testing could be included in the residence homes
avoiding any inconvenience to working time or nega-
tive impact on nursing quality. In similar studies, suc-
cessful point-of-care testing for MRSA and other
bacteria using real time PCR has already been dem-
onstrated in hospital wards [36, 37]. During this
study, it was essential to assign specimen collection
and test procedures to employees with directive func-
tion in the institution who were able to adapt work-
ing time and working schedule to collect the
specimen and perform the tests. This shows that such
measurements in residence homes would need clear
definition of responsibilities. Including all time-
consuming steps, the average time needed for 1 test-
ing procedure and 1 specimen collection procedure
was 4 min and 18 s and 3 min and 27 s, respectively.
Maximum time measured was 11 min for specimen
collection and 9 min for MRSA testing. This low
average time needed per specimen and test procedure
was a tolerable investment within this study, in par-
ticularly in the period after baseline evaluation, where
the frequency of specimen collection and testing of
specimens was strongly reduced to about 1–2 per
week. In terms of feasibility, 2 additional points needs
to be considered. From a regulatory point of view, ef-
fective structures for external and internal quality
control of such measurements in residence homes for
the elderly needs to be established since these quality
measures are mandatory in Germany [38, 39]. In
addition, performing these quality control measures
are a prerequisite for potential reimbursement of such
measurements in Germany.
The study has some limitations. Firstly, the design and
observational period of this study does not deliver a proof
that the frequency of MRSA-transmission between resi-
dents and MRSA-infections of residents can be reduced via
MRSA testing in residence homes for elderly. In a very
similar study involving 4 resident homes with 2,492 resi-
dents, screening for MRSA and subsequent hygiene inter-
vention did not result in a decrease in the prevalence of
MRSA colonization within an observational period of
28 months [40]. Therefore, a large, prospective, population-
based longitudinal study is required to define the adequate
screening interval during the long term stay in the facility
and adequate intervention methods, as recently reported
[7]. In particular, the definition of adequate screening inter-
vals are important because MRSA transmission in resident
homes is documented [7, 8] and infections can appear
shortly after acquisition. In a study conducted with adult
hospitalized patients, the majority of patients developing
clinical MRSA infection did so soon after acquisition, with
42.1% (51/121, 95% CI: 33.2 – 51.5) presenting with infec-
tion within 14 days of MRSA acquisition. This increased to
57.8% (70/121, 95% CI: 49.4 – 67.6) by 30 days and 71.9%
(87/121, 95% CI: 63.0 – 79.7) at two months [41]. In
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addition there is evidence that risk factors for pre-existing
colonization and new acquisition within nursing facilities
can differ [8].
Secondly, it should be pointed out that during this study
no measurements were performed in residents at the time
of transfer from the facility to a hospital. It has been
shown that cabin surfaces of ambulance cars transporting
hospitalized patients are at risk of MRSA contamination
and that cleaning procedures do not necessarily lead to
complete eradication of bacteria. Even if the risk for acqui-
sition during transportation in an ambulance is reported
to be very low, it cannot be excluded [42, 43]. It needs to
be taken into consideration that only nasal swabs have
been investigated to define MRSA status during this study.
Nasal swabs have the highest prediction for positive car-
rier status, but nevertheless MRSA colonization can take
place also in other body sites like throat, perineum, intes-
tine (stool) or hollow of the knee without colonization of
the nose. Relating to this, involvement of extra-nasal test-
ing body sites has been shown increased yield for MRSA
colonization of up to 30.0% [44]. This potentially has led
to an under-estimation of the true rate of colonized pa-
tients during this study and should be taken into account
for further investigations.
Conclusions
In this study, PCR-based screening for MRSA in nursing
homes for elderly, followed by culture based confirmation
in a laboratory, enabled the rapid detection of unknown
carriers. As MRSA negative residents can acquire MRSA
during a hospital stay, further spread after re-admission to
the nursing home cannot be excluded. Attention should
also be paid to nursing staff who can be carriers for MRSA
and potential sources of transmission. Additional studies
are needed to show if screening followed by interventional
hygiene measures can reduce MRSA transmission and in-
fection in such facilities. In Germany, a regulatory basis
needs to be established respecting mandatory guidelines
for quality control and reimbursement.
Abbreviation
MSSA: Methicillin sensitive Staphylococcus aureus (S, aureus without genetic
markers for resistance against Methicillin)
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